SYNDAX PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.75 USD | -1.00% |
|
-1.36% | +0.65% |
| May. 08 | Syndax Pharmaceuticals Q1 Net Loss Widens | MT |
| May. 08 | Transcript : Syndax Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.85B | - | - | - | - | - | |
| 44.96B | - | |||||
| 41.85B | ||||||
| 42.65B | ||||||
| 29.04B | ||||||
| 26.08B |
